Literature DB >> 8240284

Interaction of thrombospondin with platelet glycoproteins GPIa-IIa and GPIIb-IIIa.

M A Kowalska1, G P Tuszynski.   

Abstract

The interaction of human thrombospondin (TSP) with GPIa-IIa and GPIIb-IIIa was studied. The binding for both proteins became time-independent after 60 min. A 7-fold excess concentration of unlabelled GPIa-IIa added either initially, or after time-dependent binding, resulted in a 50% inhibition of GPIa-IIa bound to TSP. GPIa-IIa and GPIIb-IIIa specifically bound TSP since: (a) the binding of GPIIb-IIIa to TSP was dependent on the presence of 1 mM MgCl2 and 1 mM CaCl2, whereas binding of GPIa-IIa was ion-independent. (b) The binding was saturable, with dissociation constants of 0.69 +/- 0.17 microM and 3.77 +/- 1.02 microM for GPIa-IIa and GPIIb-IIIa respectively. (c) GPIIb-IIIa and GPIa-IIa did not significantly bind to BSA. (d) GPIIb-IIIa bound fibrinogen ion-specifically, whereas little or no binding of GPIa-IIa was detectable. (e) Both GPIIb-IIIa and GPIa-IIa bound collagen in an ion-independent manner. (f) GPIIb-IIIa did not compete with GPIa-IIa for binding to TSP. (g) Binding of GPIa-IIa to TSP was inhibited with anti-(GPIa-IIa) (6F1), whereas mouse IgG and anti-(GPIIb-IIIa) (AP-2) had no effect. (h) The interaction of GPIa-IIa with TSP is 5.5-fold more favourable than that of GPIIb-IIIa suggesting that GPIa-IIa may be a preferred binding protein for TSP-mediated platelet adhesion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240284      PMCID: PMC1134620          DOI: 10.1042/bj2950725

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

Authors:  J W Lawler; H S Slayter; J E Coligan
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.

Authors:  R Pytela; M D Pierschbacher; M H Ginsberg; E F Plow; E Ruoslahti
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

3.  Complex formation of platelet thrombospondin with fibrinogen.

Authors:  L L Leung; R L Nachman
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

4.  Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin.

Authors:  V M Dixit; G A Grant; S A Santoro; W A Frazier
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

5.  Role of thrombospondin in platelet aggregation.

Authors:  L L Leung
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

6.  Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia.

Authors:  H K Nieuwenhuis; J W Akkerman; W P Houdijk; J J Sixma
Journal:  Nature       Date:  1985 Dec 5-11       Impact factor: 49.962

7.  Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets.

Authors:  D Pidard; R R Montgomery; J S Bennett; T J Kunicki
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.

Authors:  J S Bennett; J A Hoxie; S F Leitman; G Vilaire; D B Cines
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction.

Authors:  G P Tuszynski; S Srivastava; H I Switalska; J C Holt; C S Cierniewski; S Niewiarowski
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

10.  Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain.

Authors:  G P Tuszynski; V L Rothman; M Papale; B K Hamilton; J Eyal
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  1 in total

1.  Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an alphaIIbbeta3- or CD36-independent mechanism.

Authors:  Anne Saumet; Nando de Jesus; Chantal Legrand; Véronique Dubernard
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.